Author’s reply – Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season

In responding to our paper on the current limitations in influenza antiviral susceptibility testing in Europe, Ciancio and Nicoll criticise our suggestions for enhanced capacity in individual countries and favour a system that, as at present, relies on resistance monitoring by predefined central laboratories, as they consider this model most effective for clinical and public health purposes during a pandemic.